Effects of novel dual GIP and GLP-1 receptor agonist tirzepatide on biomarkers of nonalcoholic steatohepatitis in patients with type 2 diabetes - Hartman, M L; Sanyal, A J; Loomba, R (Diabetes Care, 2020)